Mr. Darcy Bomford reports

TRUE LEAF SECURES EXCLUSIVE MANUFACTURER FOR PET PRODUCT LINE

True Leaf Medicine International Ltd. has signed an agreement with Wodema Industries Ltd. to produce the company's proprietary hemp-based supplements and treats for pets.

The agreement gives True Leaf proprietary rights for any production utilizing hemp, cannabis, or its derivatives at Wodema. It also includes a right of first refusal agreement to purchase Wodema's assets. Wodema Industries is a manufacturer of treats for the pet industry, doing business in Kelowna, B.C., since 1996.

In the agreement, Wodema provides True Leaf with manufacturing capacity to produce hemp-based chewable pet supplements, medication and treats.

Wodema's U.S.-approved plant gives True Leaf a currency advantage and a low-cost means of launching its own pet product line. Product formulations and packaging designs are under way and the company plans to launch to the U.S. and Canadian specialty pet industry this fall.

True Leaf chief executive officer Darcy Bomford said: "Wodema has extensive manufacturing experience and available capacity that complements our plans in the pet space perfectly. Both teams are thrilled with our agreement and anxious to hit the ground running."

Wolfgang and Colleen Thoma, founders of Wodema, said, "We're excited about this new opportunity; we've known Darcy for over 20 years and look forward to working with him and the True Leaf team."

This partnership aligns with True Leaf's quality of life value proposition as it awaits the approval of its Marihuana for Medicinal Purposes Regulations licence application. The company has made a strategic decision to enter the $53-billion pet industry with a line of pet products focused on hemp nutrition. Initially, True Leaf will market soft chews and supplements through direct, pet, natural health and veterinary channels in Canada and the United States. Ultimately it hopes to market a cannabis-based animal drug after pilot trials and regulatory approvals have been satisfied.